Clinical Trial

Pilot Study on Evaluating the Geroprotective Effect of Metformin

Study acronym: AGE-M
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-13.
Status change: Not Yet Recruiting → Recruiting 2025-03-18
Trial Details
NCT Number NCT06459310
Lead Sponsor Xuanwu Hospital, Beijing
Collaborators: Institute of Zoology, Chinese Academy of Sciences, Beijing Institute of Genomics, Chinese Academy of Sciences, Merck Serono Co., Ltd., China
Conditions Metformin, Aging
Enrollment 130 participants
Start Date 2024-06-30
Primary Completion 2026-09-30 (estimated)
Study Completion 2028-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-21